Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$9.99 - $18.71 $84,245 - $157,781
8,433 Added 71.4%
20,244 $375,000
Q2 2023

Aug 04, 2023

BUY
$9.17 - $19.29 $73 - $154
8 Added 0.07%
11,811 $130,000
Q1 2023

May 12, 2023

BUY
$12.53 - $21.71 $2,944 - $5,101
235 Added 2.03%
11,803 $158,000
Q4 2022

Feb 10, 2023

SELL
$11.61 - $16.11 $487 - $676
-42 Reduced 0.36%
11,568 $143,000
Q3 2022

Nov 14, 2022

BUY
$12.21 - $19.7 $2,002 - $3,230
164 Added 1.43%
11,610 $162,000
Q2 2022

Aug 12, 2022

SELL
$11.23 - $19.59 $10,702 - $18,669
-953 Reduced 7.69%
11,446 $158,000
Q1 2022

May 13, 2022

SELL
$13.37 - $17.79 $11,658 - $15,512
-872 Reduced 6.57%
12,399 $202,000
Q4 2021

Feb 11, 2022

SELL
$14.28 - $19.53 $29,559 - $40,427
-2,070 Reduced 13.49%
13,271 $216,000
Q3 2021

Nov 12, 2021

SELL
$12.99 - $20.47 $4,741 - $7,471
-365 Reduced 2.32%
15,341 $228,000
Q2 2021

Aug 13, 2021

BUY
$15.46 - $24.5 $9,198 - $14,577
595 Added 3.94%
15,706 $314,000
Q1 2021

May 07, 2021

BUY
$19.33 - $37.75 $773 - $1,510
40 Added 0.27%
15,111 $349,000
Q4 2020

Feb 12, 2021

SELL
$24.48 - $42.47 $10,624 - $18,431
-434 Reduced 2.8%
15,071 $372,000
Q3 2020

Nov 04, 2020

SELL
$39.09 - $53.44 $13,759 - $18,810
-352 Reduced 2.22%
15,505 $643,000
Q2 2020

Aug 12, 2020

BUY
$46.7 - $92.04 $44,972 - $88,634
963 Added 6.47%
15,857 $760,000
Q1 2020

May 04, 2020

SELL
$48.35 - $118.68 $41,629 - $102,183
-861 Reduced 5.46%
14,894 $938,000
Q4 2019

Feb 05, 2020

SELL
$57.36 - $124.1 $7,628 - $16,505
-133 Reduced 0.84%
15,755 $1.95 Million
Q3 2019

Nov 08, 2019

BUY
$58.69 - $80.46 $8,451 - $11,586
144 Added 0.91%
15,888 $1.05 Million
Q2 2019

Aug 13, 2019

BUY
$77.77 - $120.68 $138,119 - $214,327
1,776 Added 12.71%
15,744 $1.25 Million
Q1 2019

May 06, 2019

SELL
$91.83 - $120.68 $41,598 - $54,668
-453 Reduced 3.14%
13,968 $1.56 Million
Q4 2018

Feb 13, 2019

SELL
$85.79 - $126.46 $9,522 - $14,037
-111 Reduced 0.76%
14,421 $1.45 Million
Q3 2018

Nov 09, 2018

BUY
$88.49 - $127.55 $23,272 - $33,545
263 Added 1.84%
14,532 $1.84 Million
Q2 2018

Aug 08, 2018

BUY
$60.0 - $85.67 $831,600 - $1.19 Million
13,860 Added 3388.75%
14,269 $1.2 Million
Q1 2018

May 07, 2018

SELL
$52.72 - $67.25 $790 - $1,008
-15 Reduced 3.54%
409 $25,000
Q4 2017

Feb 09, 2018

BUY
$58.2 - $72.76 $24,676 - $30,850
424
424 $25,000

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.